Registry of Lobbyists
Total Number of Communication Reports: 5
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Economic Development, Health, Industry
|
Canada’s Strategic Innovation Fund, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a focus of the government’s post-COVID recovery plan.
|
Policies or Program
|
|
Health, Industry
|
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the Biomanufacturing and Life Sciences Strategy with a focus on the importance of vaccines for public health in Canada.
|
Policies or Program
|
|
Health, Industry
|
Policies regarding the availability of Novavax's COVID-19 vaccine throughout Canada.
|
Policies or Program
|
Address:
21 Firstfield Road
Gaithersburg, MD 20878
United States of America
Telephone number:
202-661-7946
Web address:
https://ca.novavax.com/
Kelly Cappio, Vice President, Policy & Government Affairs
Novavax Inc. / Novavax Inc. is not a subsidiary of any other parent companies.
Novavax Inc. / Novavax Inc. is not a coalition.
The activities of Novavax Inc. / Novavax Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Novavax Inc. / Novavax Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
WILLIAM DEMPSTER | Public offices held
Firm: 3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc.